Concord Biotech informs about closure of trading window

26 Dec 2025 Evaluate
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Concord Biotech has informed that the trading window for trading in the Equity Shares of the Company will be closed from 1st January, 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended on 31st December, 2025. Accordingly, all Designated Persons of the Company and their immediate relatives have been advised not to trade in the securities of the Company during the aforesaid Closure of Trading Window period. The company shall inform in due course, the date of the Board Meeting at which the aforesaid Unaudited Financial Results for the quarter 31st December, 2025 will be considered, approved and taken on record.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1347.60 -2.95 (-0.22%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×